Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 75


Myocardial Recovery in Patients With Systolic Heart Failure and Autoantibodies Against β1-Adrenergic Receptors.

Nagatomo Y, McNamara DM, Alexis JD, Cooper LT, Dec GW, Pauly DF, Sheppard R, Starling RC, Tang WH; IMAC-2 Investigators.

J Am Coll Cardiol. 2017 Feb 28;69(8):968-977. doi: 10.1016/j.jacc.2016.11.067.


Shared Genetic Predisposition in Peripartum and Dilated Cardiomyopathies.

Ware JS, Li J, Mazaika E, Yasso CM, DeSouza T, Cappola TP, Tsai EJ, Hilfiker-Kleiner D, Kamiya CA, Mazzarotto F, Cook SA, Halder I, Prasad SK, Pisarcik J, Hanley-Yanez K, Alharethi R, Damp J, Hsich E, Elkayam U, Sheppard R, Kealey A, Alexis J, Ramani G, Safirstein J, Boehmer J, Pauly DF, Wittstein IS, Thohan V, Zucker MJ, Liu P, Gorcsan J 3rd, McNamara DM, Seidman CE, Seidman JG, Arany Z; IMAC-2 and IPAC Investigators.

N Engl J Med. 2016 Jan 21;374(3):233-41. doi: 10.1056/NEJMoa1505517. Epub 2016 Jan 6.


Cardiac allograft vasculopathy by intravascular ultrasound in heart transplant patients: substudy from the Everolimus versus mycophenolate mofetil randomized, multicenter trial.

Kobashigawa JA, Pauly DF, Starling RC, Eisen H, Ross H, Wang SS, Cantin B, Hill JA, Lopez P, Dong G, Nicholls SJ; A2310 IVUS Substudy Investigators.

JACC Heart Fail. 2013 Oct;1(5):389-99. doi: 10.1016/j.jchf.2013.07.002. Epub 2013 Sep 11.


Managing acute decompensated heart failure.

Pauly DF.

Cardiol Clin. 2014 Feb;32(1):145-9, ix. doi: 10.1016/j.ccl.2013.09.011. Review.


Prognostic significance of biomarkers in predicting outcome in patients with coronary artery disease and left ventricular dysfunction: results of the biomarker substudy of the Surgical Treatment for Ischemic Heart Failure trials.

Feldman AM, Mann DL, She L, Bristow MR, Maisel AS, McNamara DM, Walsh R, Lee DL, Wos S, Lang I, Wells G, Drazner MH, Schmedtje JF Jr, Pauly DF, Sueta CA, Di Maio M, Kron IL, Velazquez EJ, Lee KL.

Circ Heart Fail. 2013 May;6(3):461-72. doi: 10.1161/CIRCHEARTFAILURE.112.000185. Epub 2013 Apr 12.


Everolimus versus mycophenolate mofetil in heart transplantation: a randomized, multicenter trial.

Eisen HJ, Kobashigawa J, Starling RC, Pauly DF, Kfoury A, Ross H, Wang SS, Cantin B, Van Bakel A, Ewald G, Hirt S, Lehmkuhl H, Keogh A, Rinaldi M, Potena L, Zuckermann A, Dong G, Cornu-Artis C, Lopez P.

Am J Transplant. 2013 May;13(5):1203-16. doi: 10.1111/ajt.12181. Epub 2013 Feb 22.


Implantable cardiac defibrillators and sudden death in recent onset nonischemic cardiomyopathy: results from IMAC2.

Sheppard R, Mather PJ, Alexis JD, Starling RC, Boehmer JP, Thohan V, Pauly DF, Markham DW, Zucker M, Kip KE, McNamara DM; IMAC Investigators.

J Card Fail. 2012 Sep;18(9):675-81. doi: 10.1016/j.cardfail.2012.07.004.


Myocardial recovery in peripartum cardiomyopathy: prospective comparison with recent onset cardiomyopathy in men and nonperipartum women.

Cooper LT, Mather PJ, Alexis JD, Pauly DF, Torre-Amione G, Wittstein IS, Dec GW, Zucker M, Narula J, Kip K, McNamara DM; IMAC2 Investigators.

J Card Fail. 2012 Jan;18(1):28-33. doi: 10.1016/j.cardfail.2011.09.009. Epub 2011 Nov 9.


Effect of cytochrome P450 3A5 genotype on atorvastatin pharmacokinetics and its interaction with clarithromycin.

Shin J, Pauly DF, Pacanowski MA, Langaee T, Frye RF, Johnson JA.

Pharmacotherapy. 2011 Oct;31(10):942-50. doi: 10.1592/phco.31.10.942.


Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID): a phase 2 trial of intracoronary gene therapy of sarcoplasmic reticulum Ca2+-ATPase in patients with advanced heart failure.

Jessup M, Greenberg B, Mancini D, Cappola T, Pauly DF, Jaski B, Yaroshinsky A, Zsebo KM, Dittrich H, Hajjar RJ; Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID) Investigators.

Circulation. 2011 Jul 19;124(3):304-13. doi: 10.1161/CIRCULATIONAHA.111.022889. Epub 2011 Jun 27.


The slow cardiac myosin regulatory light chain in heart failure.

Pauly DF.

Clin Cardiol. 2011 Jan;34(1):10-1. doi: 10.1002/clc.20867. No abstract available.


Association of anti-oxidized LDL and candidate genes with severity of coronary stenosis in the Women's Ischemia Syndrome Evaluation study.

Chen Q, Reis SE, Kammerer C, Craig W, McNamara DM, Holubkov R, Sharaf BL, Sopko G, Pauly DF, Merz CN, Kamboh MI; WISE study group.

J Lipid Res. 2011 Apr;52(4):801-7. doi: 10.1194/jlr.M012963. Epub 2011 Jan 20.


Renin-angiotensin gene polymorphisms and neurohormonal inhibition.

Pauly DF.

Heart Fail Clin. 2010 Jan;6(1):25-6. doi: 10.1016/j.hfc.2009.08.003. Review.


Multimarker approach predicts adverse cardiovascular events in women evaluated for suspected ischemia: results from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation.

Arant CB, Wessel TR, Ridker PM, Olson MB, Reis SE, Delia Johnson B, Sharaf BL, Pauly DF, Handberg E, Zineh I, Sopko G, Kelsey SF, Noel Bairey Merz C, Pepine CJ.

Clin Cardiol. 2009 May;32(5):244-50. doi: 10.1002/clc.20454.


Constrictive pericarditis presenting as a calcified anterior cardiac mass.

Schofield RS, Dorman SM Jr, Aranda JM Jr, Hill JA, Pauly DF, Klodell CT.

Ann Thorac Surg. 2009 May;87(5):1597-9. doi: 10.1016/j.athoracsur.2008.10.005.


Calcium upregulation by percutaneous administration of gene therapy in cardiac disease (CUPID Trial), a first-in-human phase 1/2 clinical trial.

Jaski BE, Jessup ML, Mancini DM, Cappola TP, Pauly DF, Greenberg B, Borow K, Dittrich H, Zsebo KM, Hajjar RJ; Calcium Up-Regulation by Percutaneous Administration of Gene Therapy In Cardiac Disease (CUPID) Trial Investigators.

J Card Fail. 2009 Apr;15(3):171-81. doi: 10.1016/j.cardfail.2009.01.013.


Tricuspid annular motion as a predictor of severe right ventricular failure after left ventricular assist device implantation.

Puwanant S, Hamilton KK, Klodell CT, Hill JA, Schofield RS, Cleeton TS, Pauly DF, Aranda JM Jr.

J Heart Lung Transplant. 2008 Oct;27(10):1102-7. doi: 10.1016/j.healun.2008.07.022.


Simplified method for determination of clarithromycin in human plasma using protein precipitation in a 96-well format and liquid chromatography-tandem mass spectrometry.

Shin J, Pauly DF, Johnson JA, Frye RF.

J Chromatogr B Analyt Technol Biomed Life Sci. 2008 Aug 1;871(1):130-4. doi: 10.1016/j.jchromb.2008.06.050. Epub 2008 Jul 5.


Design of a phase 1/2 trial of intracoronary administration of AAV1/SERCA2a in patients with heart failure.

Hajjar RJ, Zsebo K, Deckelbaum L, Thompson C, Rudy J, Yaroshinsky A, Ly H, Kawase Y, Wagner K, Borow K, Jaski B, London B, Greenberg B, Pauly DF, Patten R, Starling R, Mancini D, Jessup M.

J Card Fail. 2008 Jun;14(5):355-67. doi: 10.1016/j.cardfail.2008.02.005. Epub 2008 May 27.


Supplemental Content

Loading ...
Support Center